Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Leiper

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|July 8, 2005
Selective substrate-based inhibitors of mammalian dimethylarginine dimethylaminohydrolaseSharon Rossiter, Caroline L Smith, Mohammed Malaki, et al.
Circulation|September 4, 2003
Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertensionLesley J Millatt, Guy StJ Whitley, Dechun Li, et al.
Acta Histochemica|June 2, 2009
Immunolocalisation and activity of DDAH I and II in the heart and modification post-myocardial infarctionGillian A Gray, Mark Patrizio, Lorcan Sherry, et al.
Circulation|April 2, 2014
Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine"Yohannes T Ghebremariam, Jerry C Lee, Paea LePendu, et al.
Shock (Augusta, Ga.)|July 22, 2014
Overexpression of GTP cyclohydrolase 1 feedback regulatory protein is protective in a murine model of septic shockAnna Starr, Claire A Sand, Lamia Heikal, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysisBasil Hartzoulakis, Sharon Rossiter, Herpreet Gill, et al.
Plos One|August 17, 2017
Metabolomic profiling of amines in sepsis predicts changes in NOS canonical pathwaysAbel Tesfai, Niall MacCallum, Nicholas S Kirkby, et al.
Kidney International|December 17, 2009
Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphismsBen Caplin, Dorothea Nitsch, Herpreet Gill, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|July 8, 2005
Selective substrate-based inhibitors of mammalian dimethylarginine dimethylaminohydrolaseSharon Rossiter, Caroline L Smith, Mohammed Malaki, et al.
Circulation|September 4, 2003
Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertensionLesley J Millatt, Guy StJ Whitley, Dechun Li, et al.
Acta Histochemica|June 2, 2009
Immunolocalisation and activity of DDAH I and II in the heart and modification post-myocardial infarctionGillian A Gray, Mark Patrizio, Lorcan Sherry, et al.
Circulation|April 2, 2014
Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine"Yohannes T Ghebremariam, Jerry C Lee, Paea LePendu, et al.
Shock (Augusta, Ga.)|July 22, 2014
Overexpression of GTP cyclohydrolase 1 feedback regulatory protein is protective in a murine model of septic shockAnna Starr, Claire A Sand, Lamia Heikal, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysisBasil Hartzoulakis, Sharon Rossiter, Herpreet Gill, et al.
Plos One|August 17, 2017
Metabolomic profiling of amines in sepsis predicts changes in NOS canonical pathwaysAbel Tesfai, Niall MacCallum, Nicholas S Kirkby, et al.
Kidney International|December 17, 2009
Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphismsBen Caplin, Dorothea Nitsch, Herpreet Gill, et al.
Pageof 2